American Regent, Inc. initiated a recall of Vasopressin Injection, USP on May 13, 2024. The product involved is Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), supplied in a 10 mL multiple-dose vial for intravenous infusion, NDC 0517-1030-01.
The recall was classified as Class II. The stated reason is that the product was subpotent and also had out-of-specification results for impurities.
American Regent, Inc., based in Shirley, NY, is listed as the recalling firm. The recall status is listed as terminated.
This action reflects the classification and reasons stated in the recall record. It does not by itself establish that any patient was harmed by the affected product.
For readers seeking additional background, see the compound overview for vasopressin.